3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
申请人:Schering Corporation and Pharmacopeia, Inc.
公开号:US20040147559A1
公开(公告)日:2004-07-29
There are disclosed compounds of the formula
1
or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.